
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper... Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.01 | 0.408163265306 | 2.45 | 2.57 | 2.4199 | 67219 | 2.50184758 | CS |
4 | 0 | 0 | 2.46 | 2.57 | 2.33 | 94774 | 2.42659144 | CS |
12 | -0.12 | -4.6511627907 | 2.58 | 2.73 | 2.33 | 174504 | 2.53054497 | CS |
26 | 0.52 | 26.8041237113 | 1.94 | 3 | 1.84 | 482428 | 2.46001154 | CS |
52 | -22.21 | -90.028374544 | 24.67 | 32.415 | 1.25 | 573784 | 4.07957338 | CS |
156 | -9.27 | -79.0281329923 | 11.73 | 32.415 | 1.25 | 250901 | 7.61332402 | CS |
260 | -25.54 | -91.2142857143 | 28 | 32.415 | 1.25 | 222625 | 8.33130715 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions